Transcription-independent p53 apoptosis: an alternative route to death

Trends in Cell Biology

Volumn 20, Issue 1, 2010, Pages 14-24

  Speidel, Daniel ^a  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; KU ANTIGEN; PROTEIN BAK; PROTEIN BAX; PROTEIN P53;

APOPTOSIS; CANCER THERAPY; CYTOSOL; DNA DAMAGE; GENE ACTIVATION; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW; STRESS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 72549085096     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2009.10.002     Document Type: Review

References (100)

1. Hamroun D., et al. The UMD TP53 database and website: update and revisions. Hum. Mutat. 27 (2006) 14-20
2. Vazquez A., et al. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat. Rev. Drug Discov. 7 (2008) 979-987
3. Vousden K.H., and Prives C. Blinded by the light: the growing complexity of p53. Cell 137 (2009) 413-431
4. Youle R.J., and Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9 (2008) 47-59
5. Laptenko O., and Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 13 (2006) 951-961
6. Caelles C., et al. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370 (1994) 220-223
7. Haupt Y., et al. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 9 (1995) 2170-2183
8. Wagner A.J., et al. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8 (1994) 2817-2830
9. Chipuk J.E., and Green D.R. p53's believe it or not: lessons on transcription-independent death. J. Clin. Immunol. 23 (2003) 355-361
10. Moll U.M., et al. Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell Biol. 17 (2005) 631-636
11. Bennett M., et al. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282 (1998) 290-293
12. Chipuk J.E., et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303 (2004) 1010-1014
13. Leu J.I., et al. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 6 (2004) 443-450
14. Mihara M., et al. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11 (2003) 577-590
15. Green D.R., and Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 458 (2009) 1127-1130
16. Vaseva A.V., and Moll U.M. The mitochondrial p53 pathway. Biochim. Biophys. Acta 1787 (2009) 414-420
17. Dumont P., et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33 (2003) 357-365
18. Marchenko N.D., et al. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem 275 (2000) 16202-16212
19. Sansome C., et al. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett 488 (2001) 110-115
20. Akhtar R.S., et al. Neural precursor cells possess multiple p53-dependent apoptotic pathways. Cell. Death Differ. 13 (2006) 1727-1739
21. Arima Y., et al. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J. Biol. Chem. 280 (2005) 19166-19176
22. Erster S., et al. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol. Cell. Biol. 24 (2004) 6728-6741
23. Geng Y., et al. p53 transcription-dependent and -independent regulation of cerebellar neural precursor cell apoptosis. J. Neuropathol. Exp. Neurol. 66 (2007) 66-74
24. Kojima K., et al. Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. Blood 108 (2006) 993-1000
25. Mahyar-Roemer M., et al. Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells. Oncogene 23 (2004) 6226-6236
26. Nair V.D., et al. p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J. Biol. Chem. 281 (2006) 39550-39560
27. Qin H., et al. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J. Biol. Chem. 282 (2007) 5842-5852
28. Speidel D., et al. Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene 25 (2006) 940-953
29. Steele A.J., et al. p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. Blood 112 (2008) 3827-3834
30. Strom E., et al. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat. Chem. Biol. 2 (2006) 474-479
31. Todorovicc V., et al. The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J. Cell Biol. 171 (2005) 559-568
32. Waster P.K., and Ollinger K.M. Redox-dependent translocation of p53 to mitochondria or nucleus in human melanocytes after UVA- and UVB-induced apoptosis. J. Invest. Dermatol. 129 (2009) 1769-1781
33. Kojima K., et al. MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy. Blood 106 (2005) 3150-3159
34. Nemajerova A., et al. Viral and cellular oncogenes induce rapid mitochondrial translocation of p53 in primary epithelial and endothelial cells early in apoptosis. FEBS Lett. 579 (2005) 6079-6083
35. Zhao Y., et al. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res. 65 (2005) 3745-3750
36. Endo H., et al. Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J. Neurosci. 26 (2006) 7974-7983
37. Wolff S., et al. p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res. 18 (2008) 733-744
38. Hosako H., et al. Teratogen-induced activation of p53 in early postimplantation mouse embryos. Toxicol. Sci. 95 (2007) 257-269
39. Essmann F., et al. Irradiation-induced translocation of p53 to mitochondria in the absence of apoptosis. J. Biol. Chem. 280 (2005) 37169-37177
40. Pietsch E.C., et al. Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. J. Biol. Chem. 283 (2008) 21294-21304
41. Sykes S.M., et al. Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53. J. Biol. Chem. 284 (2009) 20197-20205
42. Sot B., et al. Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL. J. Biol. Chem. 282 (2007) 29193-29200
43. Tomita Y., et al. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J. Biol. Chem. 281 (2006) 8600-8606
44. Petros A.M., et al. Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR. FEBS Lett. 559 (2004) 171-174
45. Tan J., et al. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Res. 65 (2005) 9012-9020
46. Raffo A.J., et al. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis. Oncogene 19 (2000) 6216-6228
47. Chipuk J.E., et al. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4 (2003) 371-381
48. Jiang P., et al. The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis. Mol. Cell. Biol. 26 (2006) 9071-9082
49. Xu H., et al. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl. Biochem. Biophys. Res. Commun. 341 (2006) 938-944
50. Deng X., et al. Bcl2's flexible loop domain regulates p53 binding and survival. Mol. Cell. Biol. 26 (2006) 4421-4434
51. Fletcher J.I., et al. Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 18081-18087
52. Jiang M., and Milner J. Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev. 17 (2003) 832-837
53. Chipuk J.E., et al. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309 (2005) 1732-1735
54. Palacios G., and Moll U.M. Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo. Oncogene 25 (2006) 6133-6139
55. Talos F., et al. Mitochondrially targeted p53 has tumor suppressor activities in vivo. Cancer Res. 65 (2005) 9971-9981
56. Ferecatu I., et al. Tickets for p53 journey among organelles. Front. Biosci. 14 (2009) 4214-4228
57. You H., et al. Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9051-9056
58. Li M., et al. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302 (2003) 1972-1975
59. Marine J.C., et al. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 13 (2006) 927-934
60. Marchenko N.D., et al. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J. 26 (2007) 923-934
61. Dhar S.K., and St Clair D.K. Nucleophosmin blocks mitochondrial localization of p53 and apoptosis. J. Biol. Chem. 284 (2009) 16409-16418
62. Pietsch E.C., et al. The tetramerization domain of p53 is required for efficient BAK oligomerization. Cancer Biol. Ther. 6 (2007) 1576-1583
63. Moll U.M., et al. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4407-4411
64. Moll U.M., et al. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol. Cell. Biol. 16 (1996) 1126-1137
65. Moll U.M., et al. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 7262-7266
66. Ueda H., et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet. 9 (1995) 41-47
67. Ferecatu I., et al. Mitochondrial localization of the low level p53 protein in proliferative cells. Biochem. Biophys. Res. Commun. 387 (2009) 772-777
68. Tasdemir E., et al. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 10 (2008) 676-687
69. Morselli E., et al. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 7 (2008) 3056-3061
70. Nemajerova A., et al. The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ. 12 (2005) 197-200
71. Heyne K., et al. Resistance of mitochondrial p53 to dominant inhibition. Mol. Cancer 7 (2008) 54
72. Deng X., et al. Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding. Blood 113 (2009) 422-428
73. Sawada M., et al. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat. Cell. Biol. 5 (2003) 320-329
74. Yamaguchi H., et al. p53 Acetylation is crucial for its transcription-independent proapoptotic functions. J. Biol. Chem. 284 (2009) 11171-11183
75. Leu J.I., and George D.L. Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis and antagonizes the proapoptotic actions of p53 at mitochondria. Genes Dev. 21 (2007) 3095-3109
76. Ohtsuka T., et al. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat. Cell Biol. 6 (2004) 121-128
77. Zhang H., et al. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7 (2005) 909-915
78. Guo B., et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423 (2003) 456-461
79. Li N., et al. Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis. Cancer Res. 67 (2007) 11176-11185
80. Johnson T.M., et al. Knockin mice expressing a chimeric p53 protein reveal mechanistic differences in how p53 triggers apoptosis and senescence. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 1215-1220
81. Janicke R.U., et al. The dark side of a tumor suppressor: anti-apoptotic p53. Cell Death Differ. 15 (2008) 959-976
82. Yu Q. Restoring p53-mediated apoptosis in cancer cells: new opportunities for cancer therapy. Drug Resist. Updat. 9 (2006) 19-25
83. Kim E., and Deppert W. The complex interactions of p53 with target DNA: we learn as we go. Biochem. Cell Biol. 81 (2003) 141-150
84. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2 (2002) 594-604
85. Li J., and Yuan J. Caspases in apoptosis and beyond. Oncogene 27 (2008) 6194-6206
86. Taylor R.C., et al. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9 (2008) 231-241
87. Wei M.C., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292 (2001) 727-730
88. Wolter K.G., et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139 (1997) 1281-1292
89. Chao C., et al. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 19 (2000) 4967-4975
90. Jeffers J.R., et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4 (2003) 321-328
91. Jimenez G.S., et al. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet. 26 (2000) 37-43
92. Villunger A., et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302 (2003) 1036-1038
93. Uo T., et al. Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/cytoplasmic site of action in postnatal cortical neurons. J. Neurosci. 27 (2007) 12198-12210
94. Lu C., and El-Deiry W.S. Targeting p53 for enhanced radio- and chemo-sensitivity. Apoptosis 14 (2009) 597-606
95. Vassilev L.T., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 (2004) 844-848
96. Issaeva N., et al. Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nat. Med. 10 (2004) 1321-1328
97. Vassilev L.T. MDM2 inhibitors for cancer therapy. Trends Mol. Med. 13 (2007) 23-31
98. Selivanova G., and Wiman K.G. Reactivation of mutant p53: molecular mechanisms and therapeutic potential. Oncogene 26 (2007) 2243-2254
99. Vaseva A.V., et al. The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Cell Cycle 8 (2009) 1711-1719
100. Palacios G., et al. Mitochondrially targeted wild-type p53 induces apoptosis in a solid human tumor xenograft model. Cell Cycle 7 (2008) 2584-2590